205 related articles for article (PubMed ID: 32156081)
21. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
Barker RG; Wyckelsma VL; Xu H; Murphy RM
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
[TBL] [Abstract][Full Text] [Related]
22. IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.
Kostek MC; Nagaraju K; Pistilli E; Sali A; Lai SH; Gordon B; Chen YW
BMC Musculoskelet Disord; 2012 Jun; 13():106. PubMed ID: 22716658
[TBL] [Abstract][Full Text] [Related]
23. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice.
Lynch GS; Cuffe SA; Plant DR; Gregorevic P
Neuromuscul Disord; 2001 Apr; 11(3):260-8. PubMed ID: 11297941
[TBL] [Abstract][Full Text] [Related]
24. Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology.
Gehrig SM; Koopman R; Naim T; Tjoakarfa C; Lynch GS
Am J Pathol; 2010 Jan; 176(1):29-33. PubMed ID: 19959813
[TBL] [Abstract][Full Text] [Related]
25. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone secretagogues modulate inflammation and fibrosis in
Boccanegra B; Cappellari O; Mantuano P; Trisciuzzi D; Mele A; Tulimiero L; De Bellis M; Cirmi S; Sanarica F; Cerchiara AG; Conte E; Meanti R; Rizzi L; Bresciani E; Denoyelle S; Fehrentz JA; Cruciani G; Nicolotti O; Liantonio A; Torsello A; De Luca A
Front Immunol; 2023; 14():1119888. PubMed ID: 37122711
[TBL] [Abstract][Full Text] [Related]
27. Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice.
Divet A; Huchet-Cadiou C
Pflugers Arch; 2002 Aug; 444(5):634-43. PubMed ID: 12194017
[TBL] [Abstract][Full Text] [Related]
28. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
29. Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy.
Sagheddu R; Chiappalupi S; Salvadori L; Riuzzi F; Donato R; Sorci G
Hum Mol Genet; 2018 Nov; 27(21):3734-3746. PubMed ID: 30085099
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
[TBL] [Abstract][Full Text] [Related]
31. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
[TBL] [Abstract][Full Text] [Related]
32. Elevated GLUT4 and glycogenin protein abundance correspond to increased glycogen content in the soleus muscle of mdx mice with no benefit associated with taurine supplementation.
Barker RG; Frankish BP; Xu H; Murphy RM
Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29484837
[TBL] [Abstract][Full Text] [Related]
33. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
[TBL] [Abstract][Full Text] [Related]
34. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D3 deficiency promotes a slower, more oxidative skeletal muscle phenotype and ameliorates pathophysiology in the mdx mouse model of Duchenne muscular dystrophy.
Bonato A; Raparelli G; Luvisetto S; Forconi F; Cosentino M; Tirone F; Rizzuto E; Caruso M
FASEB J; 2023 Jul; 37(7):e23025. PubMed ID: 37309599
[TBL] [Abstract][Full Text] [Related]
36. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
[TBL] [Abstract][Full Text] [Related]
37. Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.
Abou-Khalil R; Yang F; Mortreux M; Lieu S; Yu YY; Wurmser M; Pereira C; Relaix F; Miclau T; Marcucio RS; Colnot C
J Bone Miner Res; 2014 Feb; 29(2):304-15. PubMed ID: 23857747
[TBL] [Abstract][Full Text] [Related]
38. Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.
Huynh T; Uaesoontrachoon K; Quinn JL; Tatem KS; Heier CR; Van Der Meulen JH; Yu Q; Harris M; Nolan CJ; Haegeman G; Grounds MD; Nagaraju K
J Pathol; 2013 Oct; 231(2):223-35. PubMed ID: 23794417
[TBL] [Abstract][Full Text] [Related]
39. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
40. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
